InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,555.74
(
-0.16%
)
US TECH 100
19,014.00
(
-1.10%
)
Dow Jones
40,358.09
(
-0.14%
)
Brent Oil
81.06
(
0.35%
)
Bitcoin
66,492.52
(
0.86%
)
Post# of 252658
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: dewophile post# 205825

Tuesday, 11/08/2016 5:29:23 PM

Tuesday, November 08, 2016 5:29:23 PM

Post# of 252658
TRIL:

to me the risk near term is immunogenicity, and the decline in leukocytes that no one is talking about



Don't say no one. I've posted multiple times that immunogenicity is something I'm curious about.

I'm also a little surprised that the abstract notes some duration of stable disease but no explicit mention of any objective responses. There were none at this point, or are the data simply being kept under wraps for now?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up